Mode
Text Size
Log in / Sign up

Meningioma

Subtypes of Meningioma

Intracranial meningioma 1

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Meningioma

10 trials tracked for Meningioma: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 12 citations.

10Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 2 Phase 2 6 Other / NA 2
  1. Phase 3 Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma Completed · 12 cited
  2. Phase 3 Magnesium and Intraoperative Blood Loss in Meningioma Surgery Completed
  3. Phase 2 Combination of Hydroxyurea and Verapamil for Refractory Meningiomas Completed
  4. Phase 2 AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas Completed
  5. Phase 2 Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) Completed
  6. Phase 2 Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Completed
Show 4 more trials
  1. Phase 2 Monthly SOM230C for Recurrent or Progressive Meningioma Completed
  2. Phase 2 T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer Completed
  3. N/A Molecular-Guided Therapy for Childhood Cancer Completed
  4. N/A Stereotactic Body Radiotherapy for Spine Tumors Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.